HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H203.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $9,000 | -40.0% | 14,455 | 0.0% | 0.00% | – |
Q2 2022 | $15,000 | -25.0% | 14,455 | 0.0% | 0.00% | – |
Q1 2022 | $20,000 | -73.7% | 14,455 | +2.9% | 0.00% | – |
Q4 2021 | $76,000 | -5.0% | 14,043 | 0.0% | 0.00% | – |
Q3 2021 | $80,000 | -2.4% | 14,043 | 0.0% | 0.00% | – |
Q2 2021 | $82,000 | – | 14,043 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HighMark Wealth Management LLC | 6,966 | $7,000 | 0.01% |
TWO SIGMA SECURITIES, LLC | 57,454 | $59,000 | 0.00% |
Virtu Financial LLC | 13,127 | $14,000 | 0.00% |
UBS Group AG | 26 | $0 | 0.00% |
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 60 | $0 | 0.00% |
OSAIC HOLDINGS, INC. | 13 | $0 | 0.00% |
WELLS FARGO & COMPANY/MN | 50 | $0 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 47,178 | $48,000 | 0.00% |
STATE STREET CORP | 14,455 | $15,000 | 0.00% |